Ryan Daws – Biography
Last update: 27 days agoExecutive profile
Ryan was Chief Financial Officer at Obsidian Therapeutics, and Managing Director, Healthcare Investment Banking at Baird. Ryan Daws joined enGene Therapeutics in 2023.
Ryan Daws is currentlyChief Financial Officer and Head of Business Development (until Jul 15 2026) at enGene Therapeutics - View - enGene Therapeutics org chart
Create your alert
to follow the career of Ryan Daws.
Education
Ryan Daws has a Master of Business Administration in International Business and Finance from University of South Carolina Darla Moore School of Business.
More about Ryan Daws
Do you need to know more about Ryan Daws? More results.
Participate
Social media
- Ryan Daws on Google News, X (Twitter), LinkedIn, YouTube
- View the pictures of Ryan Daws
The colleagues of Ryan Daws
Company Colleagues
- At enGene Therapeutics, Ryan Daws has 27 colleagues including Ron Cooper (CEO & Director), Richard Glickman (Chairman of the Board)…
Industry Colleagues
- In the Biotechnology industry, Ryan Daws has 35,915 colleagues in 2,426 companies located in 45 countries. 16,995 executive movements have been recorded in the last 12 months. Learn more about Biotechnology.
Get in Touch
Here are a few tips for establishing great contacts.
